摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-phenyloxazole | 142075-59-0

中文名称
——
中文别名
——
英文名称
4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-phenyloxazole
英文别名
4-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-phenyl-oxazole;Tert-butyl-dimethyl-[2-(2-phenyl-1,3-oxazol-4-yl)ethoxy]silane
4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-phenyloxazole化学式
CAS
142075-59-0
化学式
C17H25NO2Si
mdl
——
分子量
303.476
InChiKey
WCKTXXYKOOVLRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.91
  • 重原子数:
    21.0
  • 可旋转键数:
    5.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    35.26
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-phenyloxazole 在 oxygen 作用下, 以 甲醇 为溶剂, 以73%的产率得到N-(3-((tert-butyldimethylsilyl)oxy)propanoyl)-N-formylbenzamide
    参考文献:
    名称:
    2-phenyloxazolines as carboxylate precursors - applications to the synthesis of asymmetric branched-chain structures
    摘要:
    A synthetic approach to the title compounds is presented that features the asymmetric elaboration of a chiral, non-racemic oxazoline followed by a two-step oxidative ring cleavage of the heterocycle to a triamide for further transformation.
    DOI:
    10.1016/s0040-4039(00)79046-0
  • 作为产物:
    描述:
    (S)-4-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-phenyl-4,5-dihydro-oxazole2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 为溶剂, 以85%的产率得到4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-phenyloxazole
    参考文献:
    名称:
    2-phenyloxazolines as carboxylate precursors - applications to the synthesis of asymmetric branched-chain structures
    摘要:
    A synthetic approach to the title compounds is presented that features the asymmetric elaboration of a chiral, non-racemic oxazoline followed by a two-step oxidative ring cleavage of the heterocycle to a triamide for further transformation.
    DOI:
    10.1016/s0040-4039(00)79046-0
点击查看最新优质反应信息

文献信息

  • [EN] DEUTERATED COMPOUNDS<br/>[FR] COMPOSÉS DEUTÉRÉS
    申请人:[en]ALEBUND PHARMACEUTICALS (HONG KONG) LIMITED
    公开号:WO2023016440A1
    公开(公告)日:2023-02-16
    Disclosed herein are compounds according to formula (I), the pharmaceutical composition comprising the same, and uses thereof.
查看更多